People

Michele  Y.  Splinter , Pharm.D., BCPS

Associate Professor

Department of Pharmacy: Clinical and Administrative Sciences

Phone (405) 271-6878  x47266
Office   CPB209
Email Michele-Splinter@ouhsc.edu

Research Summary

Specialties
Neurology, Pharmacokinetics
 
Research Interests
Neurology, Pharmacokinetics, Adult Medicine. Research includes thromboembolic prophylaxis and medication use in rehabilitation medicine.
 

Education & Experience

Education
  • University of Oklahoma, Norman, Oklahoma. Received Bachelor of Science degree in Pharmacy in December, 1973, 1969-1973
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. Received degree of Master in Pharmaceutical Sciences in May, 1988, 1986-1988
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. Received degree of Doctor of Pharmacy in June, 1995, 1993-1995
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. Postdoctoral Residency in Clinical Pharmacokinetics. Preceptor:  Michael E. Burton, Pharm.D., 1995-1996
Professional Experience
  • Staff Pharmacist, Southwest Medical Center of Oklahoma, 4401 S. Western, Oklahoma City, Oklahoma 73109 (1979-1994) 1979-1994
  • Clinical Assistant Professor, Department of Pharmacy Practice, College of Pharmacy, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, Director of Pharmacy Practice Laboratory (June 1991-July 1993), Coordinator Hospital Practicum (January 1992-April 1996) 1991-1995
  • Clinical Instructor, Department of Pharmacy Practice, College of Pharmacy, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma  1995-1996
  • Consultant, IV Services of Oklahoma, Oklahoma City, Oklahoma 1996-1997
  • Clinical Assistant Professor, Department of Pharmacy: Clinical and Administrative Sciences, College of Pharmacy, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, Coordinator Pharmaceutical Care Module IV:  Neurology (2001-present), Therapeutic Drug Monitoring Service (July 1996-September 1997),
  • Director of Pharmacy Practice Laboratory (June 1996-September 1997)• Clinical Specialist, Rehabilitation Medicine. Jim Thorpe Rehabilitation Hospital, Oklahoma City, Oklahoma (1998-2004)  1996-2003
  • Clinical Associate Professor, Department of Pharmacy: Clinical and Administrative Sciences, College of Pharmacy, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 2003-Present
Teaching Experience
  • PHAR 7094 Clinical Rotation in Rehabilitation Medicine and Adult Medicine, October 1998-2004
  • PHAR 7842 Co-Coordinator for Pharmaceutical Care Module IV: Neurology.  Pharmacotherapy of Parkinson’s Disease, Pharmacotherapy for Headaches, Antiepileptic Pharmacokinetics, and Antiepileptic Pharmacotherapy, Spring 2000-present
  • PHAR 7832 Clinical Pharmacokinetics of Psychotherapeutic Agents (2000-present) and Phenytoin (2004-present) for Clinical Pharmacokinetics
  • PA 7106 Parkinson’s Disease and Seizures and Status Epilepticus for Pharmacotherapeutics, Spring 2000-present
  • PERI 5012-PHSC 5012.  Co-Coordinator Advanced Clinical Pharmacotherapeutics. Basic Principles of Clinical Pharmacology, Spring 2005.
  • PHSC 5010 Seizures and Status Epilepticus for Clinical Pharmacotherapeutics, Spring 2000-04
  • PHAR 7094 Neurology Selective (Pharm.D. students) 2006-present

Honors & Service

Service
  • 2010-2011 Chair, Scholarship Committee, OSHP
view full profile

Selected Publications & Presentations

  1. Splinter M Y. Cognitive Disorders In Press;
  2. Knapp K K, Meszaros K, Goldsmith P C, McCarter G C, Hester E K, McBane S E, Bottorff M B, Carnes T A, Dell K, Gonyeau M J, Greco A J, McConnell K J, Skaar D J, Splinter M Y, Trujillo T C. Alternative Viewpoint: Preparation for Residency Pharmacotherapy. 2014; 34: e157-e158.
  3. Hester E K, McBane S E, Bottorff M B, Carnes T A, Dell K, Gonyeau M J, Greco A J, McConnell K J, Skaar D J, Splinter M Y, Trujillo T C. Educational Outcomes Necessary to Enter Pharmacy Residency Training Pharmacotherapy: The Journal of Pharmacology and Drug Therapy/Wiley Periodicals, Inc. 2014; 34: e22-e25.
  4. Splinter M Y. Splinter MY. Efficacy of retigabine in adjunctive treatment of partial onset seizures in adults. J Cent Nerv Syst Dis 2013;5:31–41. DOI: 10.4137/JCNSD.S9299 J Cent Nerv Syst Dis. 2013; 5: 31-41.